InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,024.86
(
0.37%
)
Post# of 353140
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Past and present

Send PM Follow Ignore
Followers 43
Posts 8476
Boards Moderated 3
Alias Born 11/23/2003

Past and present

Member Level

Re: None

Friday, 01/20/2017 2:30:23 PM

Friday, January 20, 2017 2:30:23 PM

Post# of 353140
***PKTX.. Just a Thought..
Most biotechs in clinical trials trade around the $1-$2 level. The insulin market is a $39 billion dollar a year industry. As news starts to spread about AAGP and the company that owns it we will see a rush to own the stock as people will start to realize that the AAGP molecule won't be unknown for long. If the company was trying to get the molecule into trials by itself it would take years. Having the Edmonton Protocol and Dr Shapiros team and the Univ of Alberta as sponsors makes this application an incredible feat. The possibilities are endless.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up